HMGB1 and cystic fibrosis-related diabetes: Two previous studies, carried out in subjects with cystic fibrosis-related diabetes and in a lipopolysaccharide-induced septic rat model, respectively, have shown that HMGB1 was increased in the presence of hyperglycaemia and was lowered after insulin therapy [10, 25].